{
    "2019-09-16": [
        [
            {
                "time": "",
                "original_text": "中信建投医药|行业周报】关注外资持股及CS-CO大会 继续配置高性价比品种",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "外资持股",
                        "CS-CO大会",
                        "高性价比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报: 关注医保改革新动向，继续看好创新升级",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场周报",
                        "医保改革",
                        "创新升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}